tiprankstipranks
Advertisement
Advertisement

BVNRY Stock Latest News

Bavarian Nordic Lifts Guidance After Robust Q1 Call
Company AnnouncementsBavarian Nordic Lifts Guidance After Robust Q1 Call
12d ago
BVNRY
Bavarian Nordic’s Phase 3b Chikungunya Vaccine Trial Sets Up a New Catalyst for BVNRY Investors
PremiumCompany Announcements
Bavarian Nordic’s Phase 3b Chikungunya Vaccine Trial Sets Up a New Catalyst for BVNRY Investors
2M ago
BVNRY
Bavarian Nordic’s Earnings Call: Strong Growth Amid Challenges
PremiumCompany Announcements
Bavarian Nordic’s Earnings Call: Strong Growth Amid Challenges
6M ago
BVNRY
Bavarian Nordic Reports Strong Revenue Growth in 2025
PremiumCompany Announcements
Bavarian Nordic Reports Strong Revenue Growth in 2025
6M ago
BVNRY
New Phase 2b Trial by Icon Plc and Bavarian Nordic: A Closer Look at MVA-BN Vaccine Developments
PremiumCompany Announcements
New Phase 2b Trial by Icon Plc and Bavarian Nordic: A Closer Look at MVA-BN Vaccine Developments
7M ago
ICLR
Bavarian Nordic’s CHIKV VLP Vaccine Study: A Potential Game-Changer in Pediatric Immunization
PremiumCompany AnnouncementsBavarian Nordic’s CHIKV VLP Vaccine Study: A Potential Game-Changer in Pediatric Immunization
7M ago
BVNRY
Bavarian Nordic’s MVA-BN Vaccine Study: A Potential Game-Changer in Orthopoxvirus Prevention
Premium
Company Announcements
Bavarian Nordic’s MVA-BN Vaccine Study: A Potential Game-Changer in Orthopoxvirus Prevention
7M ago
BVNRY
Officials confirm community spread of new Mpox strain in Southern CA, NBC says
Premium
The Fly
Officials confirm community spread of new Mpox strain in Southern CA, NBC says
7M ago
EBS
Bavarian Nordic Reports Strong Earnings and Growth
PremiumCompany Announcements
Bavarian Nordic Reports Strong Earnings and Growth
9M ago
BVNRY
Bavarian Nordic Reports Strong H1 2025 Results
PremiumCompany Announcements
Bavarian Nordic Reports Strong H1 2025 Results
9M ago
BVNRY
Bavarian Nordic’s CHIKV VLP Vaccine Study: A Potential Game-Changer in Pediatric Chikungunya Prevention
PremiumCompany Announcements
Bavarian Nordic’s CHIKV VLP Vaccine Study: A Potential Game-Changer in Pediatric Chikungunya Prevention
10M ago
BVNRY
Bavarian Nordic’s Phase 2 Vaccine Trial Update: Key Insights for Investors
PremiumCompany Announcements
Bavarian Nordic’s Phase 2 Vaccine Trial Update: Key Insights for Investors
10M ago
BVNRY
Bavarian Nordic Reports Strong Q1 2025 Growth
PremiumCompany AnnouncementsBavarian Nordic Reports Strong Q1 2025 Growth
1y ago
BVNRY
Bavarian Nordic’s Earnings Call: Strong Growth and Positive Outlook
Premium
Company Announcements
Bavarian Nordic’s Earnings Call: Strong Growth and Positive Outlook
1y ago
BVNRY
Bavarian Nordic A/S Reports Strong 2024 Earnings Amid Challenges
Premium
Company Announcements
Bavarian Nordic A/S Reports Strong 2024 Earnings Amid Challenges
1y ago
BVNRY
Bavarian Nordic Reports Strong 2024 Growth
PremiumCompany Announcements
Bavarian Nordic Reports Strong 2024 Growth
1y ago
BVNRY
Bavarian Nordic Reports Strong Travel Health Growth in 2024
PremiumCompany Announcements
Bavarian Nordic Reports Strong Travel Health Growth in 2024
2y ago
BVNRY
Study suggests waning mpox protection from Jynneos vaccine, CIDRAP reports
PremiumThe Fly
Study suggests waning mpox protection from Jynneos vaccine, CIDRAP reports
2y ago
EBS
GOVX
Bavarian Nordic announces commercial availability of VAXCHORA in Canada
PremiumThe Fly
Bavarian Nordic announces commercial availability of VAXCHORA in Canada
2y ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
2y ago
EBS
MRVI
Applied Materials, H&R Block report quarterly beats: Morning Buzz
Premium
The Fly
Applied Materials, H&R Block report quarterly beats: Morning Buzz
2y ago
PL
FLO
Logistical issues with vaccine pose risk to mpox response, FT reports
Premium
The Fly
Logistical issues with vaccine pose risk to mpox response, FT reports
2y ago
EBS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >